☰

Chawnshang Chang

Affiliations: 
University of Rochester, Rochester, NY 
Area:
Neuroscience Biology
Google:
"Chawnshang Chang"
Mean distance: 5624.53
 
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Hui-Kuan Lin grad student 2002 Rochester
Chih-Rong Shyr grad student 2002 Rochester
Huei-Ju Ting grad student 2002 Rochester
Yueh-Chiang Hu grad student 2003 Rochester
Wen-Jye Lin grad student 2003 Rochester
Mujib M. Rahman grad student 2003 Rochester
Saleh Altuwaijri grad student 2004 Rochester
Kuang-Hsiang Chuang grad student 2004 Rochester
Cheng-Lung Hsu grad student 2004 Rochester
Yei-Tsung Chen grad student 2006 Rochester
Shaozhen Xie grad student 2007 Rochester
Ning-Chun Liu grad student 2008 Rochester
Jiann-Jyh Lai grad student 2009 Rochester
Kuo-Pao Lai grad student 2010 Rochester
Wen-Lung Ma grad student 2010 Rochester
Chiung-Kuei Huang grad student 2011 Rochester
Shin-Jen Lin grad student 2013 Rochester
Tzu-Hua Lin grad student 2013 Rochester

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yang Y, Sheng J, Hu S, et al. (2022) Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis. Cell Death & Disease. 13: 533
Zhang M, Sun Y, Huang CP, et al. (2021) Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression. Cell Death & Disease. 12: 855
Deng G, Wang R, Sun Y, et al. (2021) Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals. Cell Death and Differentiation
Lee SO, Ma Z, Yeh CR, et al. (2021) Corrigendum to: 'New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells'. Journal of Molecular Cell Biology
You B, Sun Y, Luo J, et al. (2021) Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR. Oncogene
Tian H, Chou FJ, Tian J, et al. (2021) ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling. Journal of Experimental & Clinical Cancer Research : Cr. 40: 3
Hu YC, Yeh S, Yeh SD, et al. (2020) Correction: Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. The Journal of Biological Chemistry. 295: 17382
Hu YC, Yeh S, Yeh SD, et al. (2020) Correction: Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. The Journal of Biological Chemistry. 295: 17382
Tian J, Ok Lee S, Liang L, et al. (2020) Correction: Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis. The Journal of Biological Chemistry. 295: 16469
Lin TH, Lee SO, Niu Y, et al. (2020) Correction: Differential androgen deprivation therapies with anti-androgens Casodex/bicalutamide or MDV3100/enzalutamide anti-androgen receptor ASC-J9 lead to promotion suppression of prostate cancer metastasis. The Journal of Biological Chemistry. 295: 15796
See more...